Intrapartum Monitoring Devices Market Size is expected to witness a substantial CAGR from 2022 to 2028 owing to the rising demand for better ways of fetal evaluation during labor. The industry growth is propelled by increasing advancements in non-invasive monitoring technology and the growing adoption of electronic fetal monitoring across various regions. Furthermore, rising development of new devices equipped with advanced signal acquisition and processing through additional setups and electrodes is set to drive product demand in the coming years.
Based on type, the electrode segment is estimated to record considerable growth through 2028 driven by the surging usage of electrodes in internal fetal heart rate monitoring devices. Wire electrodes, sometimes dubbed as scalp or spiral electrodes, are usually attached to the fetal scalp via the cervical opening and are then connected to the monitor. This allows internal monitoring methods to provide consistent and accurate transmission when closer surveillance is required or external monitoring techniques are inadequate.
Considering the end-user industry, the intrapartum monitoring devices market is projected to register lucrative expansion from the hospitals segment by 2028. This is on account of the gradual increase in elderly pregnant women across various regions. The segment growth is further set to increase owing to the availability of healthcare professionals and different types of fetal heart rate monitoring equipment in hospitals. The traditional diagnosis and treatment model is centered on the hospital as the main body, leading to increased product adoption across these establishments.
By region, the North America intrapartum monitoring devices market share is estimated to foresee remarkable growth over the forecast period. This rise is attributed to the increasing advocation of fetal monitoring software and processes by various organizations in the region. For instance, according to the American College of Obstetricians and Gynecologists, intermittent fetal monitoring with a stethoscope, handheld doppler, and electronic fetal monitor can be utilized for monitoring low-risk women during labor. The regional expansion is set to be propelled by the availability of different diagnosis and treatment options across different countries.
Major companies across the intrapartum monitoring devices market include Mindchild Medical, Neoventa Medical, GE Healthcare, Huntleigh Healthcare Limited, Rocket Medical, Cardinal Health, and others. These players are focusing on the implementation of capacity expansion and strategic initiatives such as partnerships, collaborations, mergers, acquisitions, and novel product developments for maintaining their position in the market.
For instance, Philips’ Avalon FM fetal and maternal monitors provide automated coincidence detection with the help of Smart Pulse. The device offers separate maternal monitoring and fetal heart rate monitoring for enhancing diagnostic confidence.
The SARS-CoV-2 pandemic has escalated the requirement for continuous electronic fetal monitoring owing to an increased frequency of non-reassuring tracings among pregnant patients with confirmed or suspected COVID-19. While the virus has been rarely detected in amniotic fluid or vaginal secretions, internal fetal heart rate monitoring could be performed for usual indications.
Furthermore, it is to be noted that fetal and maternal monitoring procedures are typically routine in laboring patients diagnosed with COVID-19, who are not severely ill. This has created the need for advanced solutions, opening avenues for product developments across the intrapartum monitoring devices industry through the pandemic period.
Market, by Product
The above information is provided for the following regions and countries: